Intestinal perforation in recurrent cervical cancer following bevacizumab and pembrolizumab therapy: A case report
Anti-angiogenic drugs and immunotherapy drugs each have their own side effects, and the occurrence of adverse reactions becomes more complex when used in combination. In the clinical process of combined medication, more attention should be paid to adverse reactions, early identification of severe adverse reactions, and active management.
Authors
- Yongchun Fu (ORCID: https://orcid.org/0000-0002-8650-9507)
- Yuanchun Fan
- Jianguo Zhao (ORCID: https://orcid.org/0000-0003-4877-8690)
- Shihao Liu (ORCID: https://orcid.org/0009-0007-4463-3191)
- Chunyang Wang (ORCID: https://orcid.org/0009-0003-5408-9397)
- Hui Zhang (ORCID: https://orcid.org/0000-0001-6300-9334)
- Jiahui Yang (ORCID: https://orcid.org/0009-0009-4578-8624)
Institutions
- Hebei Medical University (CN)
- Fourth Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Medicine
- Published
- 2025-04-11
- DOI
- https://doi.org/10.1097/md.0000000000040473
- Citations
- 1
- Primary Topic
- Colorectal and Anal Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 2.01